Leaflet:information for the user
Celestoderm 1mg/g+1mg/g cream
Betamethasone (as valerate)/Gentamicin (as sulfate)
Read the entire leaflet carefully before starting to use this medicine,as it contains important information for you.
Contents of the leaflet
It is a combination of an anti-inflammatory (a corticosteroid) and an aminoglycoside antibiotic for skin administration.
Antibiotics are used to treat bacterial infections and are not effective against viral infections. It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor. Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash. |
It is indicated for the local treatment of dermatoses (skin conditions) that respond to corticosteroids and are complicated by secondary infections caused by gentamicin-sensitive microorganisms.
Do notuse Celestodermcream
Warnings and precautions
Consult your doctor or pharmacist before starting to use Celestoderm cream.
Children
The use of this medicine is not recommended in children under 12 years of age.
In children, it is more likely that the corticosteroid will pass into the body through the skin and have adverse effects in other areas of the body than in adult patients.
In children treated with topical corticosteroids, adrenal gland disorders have been reported, which can cause symptoms such as obesity, growth retardation, etc. (Cushing's syndrome) or increased intracranial pressure (intracranial hypertension) that can manifest as, among other signs, bulging fontanelle in infants and headaches.
Using Celestoderm cream with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
No interactions with other medicines are known for Celestoderm cream.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using any medicine.
Pregnancy
As a general rule, during the first trimester of pregnancy, the cream should not be applied.
This medicine should not be used during pregnancy unless your doctor considers that the potential benefit of its use justifies the potential risk to the fetus.
Pregnant women or those planning to become pregnant should not use this medicine on large areas of skin, for prolonged periods, or with occlusive dressings.
Breastfeeding
Do not apply this medicine to the breasts during breastfeeding; do not let the child come into contact with treated areas.
Do not use this medicine on large areas of skin, for prolonged periods, or with occlusive dressings.
Driving and using machines
Treatment with this medicine does not affect the ability to drive or use machines.
Celestoderm cream contains cetyl stearyl alcohol and chlorocresol
This medicine may cause local skin reactions (such as contact dermatitis) because it contains cetyl stearyl alcohol.
This medicine may cause allergic reactions because it contains chlorocresol.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is:
Adults and children over 12 years
Apply a thin layer of this medicine to the entire affected area 2 times a day, in the morning and at night.
The frequency of application should be determined by your doctor according to the severity of the condition.
In some mild cases, one application may be sufficient, but in more complicated cases, 3 applications per day may be needed.
The treatment duration should not exceed 2 weeks. If you use the medicine for a condition on the face, the treatment should be as short as possible, up to a maximum of one week.
If you do not observe improvement within these time periods, consult your doctor.
Topical use.
The cream should be applied with a gentle massage to the entire affected area.
Use in children
Celestoderm cream is not recommended for children under 12 years of age.
If you use more Celestoderm cream than you should
Excessive use of topical corticosteroids (repeated overdoses) may cause adverse effects (see section 4).
A single overdose of gentamicin is not expected to cause symptoms. Excessive or prolonged use of topical antibiotics may lead to the proliferation of non-sensitive fungi or bacteria in the lesions.
Treatment of overdose is symptomatic. The acute symptoms of excessive corticosteroid use are generally reversible. In cases of chronic toxicity, it is recommended that corticosteroids be withdrawn gradually, and if non-sensitive microorganism proliferation occurs, treatment with Celestoderm cream should be discontinued, and appropriate therapy should be applied.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or go to a medical center, or call the Toxicology Information Service. Tel.: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Celestoderm cream
Do not apply a double dose to make up for forgotten doses.
Apply the dose as soon as possible and then continue with your usual treatment.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported, very rarely, with the use of Celestoderm cream: allergies, rashes, and changes in skin color.
Treatment with gentamicin has caused transient irritation (erythema and pruritus) that generally did not require treatment discontinuation.
The following reactions have been reported with the use of topical corticosteroids, especially after prolonged application, on large areas, with occlusive dressings, and/or in children:
This, for example, can increase eye pressure (glaucoma) or may cause a condition characterized by a rounded face, fat accumulation, hump, delayed wound healing, psychiatric symptoms, etc. (Cushing's syndrome); increased blood pressure, fluid retention (edema), decreased potassium levels in the blood (hypokalemia), osteoporosis, thyroid disorders (hyperthyroidism), increased cholesterol and triglycerides, increased blood sugar levels (hyperglycemia), stomach ulcers, cataracts, blurred vision with unknown frequency (cannot be estimated from available data), hair loss, increased hair growth, specific skin inflammation around the upper lip and chin (perioral dermatitis), changes in skin pigmentation, paresthesia (an abnormal skin sensation, such as numbness, tingling, pins and needles, burning, or itching of the skin).
Reporting of side effects:
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency's website (https://www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required. Use within 3 months after opening. Indicate the opening date on the outer packaging.
Do not use this medicine after the expiry date stated on the packaging after CAD. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Celestoderm cream composition
Each gram of cream contains 1 mg of betamethasone and 1 mg of gentamicin.
Appearance of the product and pack contents
Celestoderm cream is a white cream.
It is available in tubes containing 30 and 50 grams of cream.
Marketing authorization holder and manufacturer
Marketing authorization holder
Organon Health, S.L.
Paseo de la Castellana, 77
28046 Madrid
Spain
Tel.: 915911279
Manufacturer
Organon Heist bv
Industriepark 30
2220 Heist-op-den-Berg
Belgium
Date of the last revision of this leaflet: September 2017.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)